Flexible clauses in the TRIPS agreement and access to essential medicine from the perspectives of global health governance
Wang D., Zhao YX., Tang K.
In global health governance, the balance between accessibility to essential medicines and the research and development of pharmaceuticals has been a long-standing issue. Because of the diverged national interests, the developed and developing countries pursue different strategies in their negotiations at various global health governance platforms. This study examines the flexible clauses in the TRIPS agreement and the different standpoints of both developed and developing countries, and proposes that China should take full advantage of the flexible clauses in its global health governance to protect the interests of developing countries.